Tranexamic acid for the reduction of blood loss in total knee arthroplasty.

about

Is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty? A meta-analysis of randomized controlled trials.EFFECT OF TRANEXAMIC ACID ON BLEEDING CONTROL IN TOTAL KNEE ARTHROPLASTY.

P2860

Q36350331-2E3C2D77-9C59-4155-A5B5-2B06E82B29E9 Q36892159-2E701ECC-48E7-47DF-9C93-57951074050F

P2860

Tranexamic acid for the reduction of blood loss in total knee arthroplasty.

Item

http://www.wikidata.org/entity/Q40858444

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Tranexamic acid for the reduction of blood loss in total knee arthroplasty.

@en

type

Item

label

Tranexamic acid for the reduction of blood loss in total knee arthroplasty.

@en

prefLabel

Tranexamic acid for the reduction of blood loss in total knee arthroplasty.

@en

P1476

Tranexamic acid for the reduction of blood loss in total knee arthroplasty.

@en

P2093

Kresimir Oremus

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

Hemostatic drugs

Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety

Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients.

A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement.

Perioperative blood transfusions in orthopaedic surgery.

Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management*.

The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty.

Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030

Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery.

P304

S40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3978/J.ISSN.2305-5839.2015.03.35

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26046088

http://www.w3.org/2001/XMLSchema#string

P932

4437933

http://www.w3.org/2001/XMLSchema#string

Tranexamic acid for the reduction of blood loss in total knee arthroplasty.

about

P2860

P2860

Tranexamic acid for the reduction of blood loss in total knee arthroplasty.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932